{"date":"2025-10-01","count":20,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6493-2025-10-01-1853-11wio74","company_id":"6493","company":"雷虎生","market":"興櫃","industry":"生技醫療","date":"2025-10-01","time":"18:53:22","subject":"公告本公司第六屆薪資報酬委員會委員任期屆滿","clause":"第6款","fact_date":"2025-10-01","cite_as":"公開資訊觀測站重大訊息：雷虎生（6493），2025-10-01 18:53，「公告本公司第六屆薪資報酬委員會委員任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6493-2025-10-01-1844-1bg34sn","company_id":"6493","company":"雷虎生","market":"興櫃","industry":"生技醫療","date":"2025-10-01","time":"18:44:47","subject":"公告本公司新任董事解除董事及其代表人競業禁止之限制","clause":"第22款","fact_date":"2025-10-01","cite_as":"公開資訊觀測站重大訊息：雷虎生（6493），2025-10-01 18:44，「公告本公司新任董事解除董事及其代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6493-2025-10-01-1842-m5k2rq","company_id":"6493","company":"雷虎生","market":"興櫃","industry":"生技醫療","date":"2025-10-01","time":"18:42:57","subject":"公告本公司114年10月01日股東臨時會之重要決議事項","clause":"第15款","fact_date":"2025-10-01","cite_as":"公開資訊觀測站重大訊息：雷虎生（6493），2025-10-01 18:42，「公告本公司114年10月01日股東臨時會之重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2025-10-01-1836-1tcf5wm","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2025-10-01","time":"18:36:40","subject":"代子公司阿原工作室股份有限公司向關係人租賃取得不動產使用權資產","clause":"第20款","fact_date":"2025-09-30","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2025-10-01 18:36，「代子公司阿原工作室股份有限公司向關係人租賃取得不動產使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6493-2025-10-01-1827-1gajc8e","company_id":"6493","company":"雷虎生","market":"興櫃","industry":"生技醫療","date":"2025-10-01","time":"18:27:41","subject":"本公司董事會選任董事長","clause":"第6款","fact_date":"2025-10-01","cite_as":"公開資訊觀測站重大訊息：雷虎生（6493），2025-10-01 18:27，「本公司董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2025-10-01-1824-631977","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2025-10-01","time":"18:24:31","subject":"公告本公司於114年10月2日召開投資人可參與之重大訊息說明記者會","clause":"第53款","fact_date":"2025-10-01","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2025-10-01 18:24，「公告本公司於114年10月2日召開投資人可參與之重大訊息說明記者會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2025-10-01-1823-xf3k0e","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2025-10-01","time":"18:23:44","subject":"本公司因有重大訊息待公布，經櫃買中心同意自114年10月2日起暫停交易","clause":"第40款","fact_date":"2025-10-01","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2025-10-01 18:23，「本公司因有重大訊息待公布，經櫃買中心同意自114年10月2日起暫停交易」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6493-2025-10-01-1822-1br7hrl","company_id":"6493","company":"雷虎生","market":"興櫃","industry":"生技醫療","date":"2025-10-01","time":"18:22:35","subject":"本公司114年股東臨時會改選董監事名單","clause":"第6款","fact_date":"2025-10-01","cite_as":"公開資訊觀測站重大訊息：雷虎生（6493），2025-10-01 18:22，「本公司114年股東臨時會改選董監事名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2025-10-01-1703-9l89zk","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-10-01","time":"17:03:06","subject":"公告法人董事指派代表人出席114/10/01董事會","clause":"第6款","fact_date":"2025-10-01","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-10-01 17:03，「公告法人董事指派代表人出席114/10/01董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-10-01-1600-1clev7o","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-10-01","time":"16:00:19","subject":"代子公司太景生物科技股份有限公司公告與Fideschem Inc.及Newsun Pharmaceutical JSC. 簽署「奈諾沙星三方授權協議」。","clause":"第10款","fact_date":"2025-10-01","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-10-01 16:00，「代子公司太景生物科技股份有限公司公告與Fideschem Inc.及Newsun Pharmaceutical JSC.」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-10-01-1559-1vb8x25","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-10-01","time":"15:59:42","subject":"公告本公司委任薪資報酬委員會委員","clause":"第6款","fact_date":"2025-10-01","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-10-01 15:59，「公告本公司委任薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-10-01-1559-ps7z81","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-10-01","time":"15:59:15","subject":"公告本公司獨立董事辭任功能性委員會職務","clause":"第6款","fact_date":"2025-10-01","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-10-01 15:59，「公告本公司獨立董事辭任功能性委員會職務」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-10-01-1558-1p3cw4y","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-10-01","time":"15:58:53","subject":"公告本公司獨立董事辭職","clause":"第6款","fact_date":"2025-10-01","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-10-01 15:58，「公告本公司獨立董事辭職」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2025-10-01-1555-1hkj5dk","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-10-01","time":"15:55:17","subject":"係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解","clause":"第51款","fact_date":"2025-10-01","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-10-01 15:55，「係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1777-2025-10-01-1531-i94byr","company_id":"1777","company":"生泰","market":"上櫃","industry":"生技醫療","date":"2025-10-01","time":"15:31:33","subject":"公告本公司處分不動產使用權資產(提前終止租約)","clause":"第20款","fact_date":"2025-10-01","cite_as":"公開資訊觀測站重大訊息：生泰（1777），2025-10-01 15:31，「公告本公司處分不動產使用權資產(提前終止租約)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2025-10-01-1506-ps7z81","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2025-10-01","time":"15:06:34","subject":"公告本公司獨立董事辭任功能性委員會職務","clause":"第6款","fact_date":"2025-10-01","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2025-10-01 15:06，「公告本公司獨立董事辭任功能性委員會職務」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2025-10-01-1505-qrsqda","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2025-10-01","time":"15:05:43","subject":"公告本公司獨立董事辭任","clause":"第6款","fact_date":"2025-10-01","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2025-10-01 15:05，「公告本公司獨立董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-10-01-1355-1r1s08i","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-10-01","time":"13:55:40","subject":"公告本公司114年第三季個別財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-10-01 13:55，「公告本公司114年第三季個別財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2025-10-01-1355-q203yi","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2025-10-01","time":"13:55:40","subject":"公告本公司重要營運主管異動案","clause":"第8款","fact_date":"2025-10-01","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2025-10-01 13:55，「公告本公司重要營運主管異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2025-10-01-0605-8nf7h2","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2025-10-01","time":"06:05:06","subject":"公告本公司505(b)(2)新劑型新藥TAH3311抗血栓口溶膜送美國藥證申請","clause":"第44款","fact_date":"2025-10-01","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2025-10-01 06:05，「公告本公司505(b)(2)新劑型新藥TAH3311抗血栓口溶膜送美國藥證申請」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}